Table 4.
Univariate Analysis |
Multivariate Analysis |
|||||
---|---|---|---|---|---|---|
Baseline Variables | HR | 95%CI | P value | HR | 95% CI | P |
Groupa | 0.648 | 0.407-0.946 | .027 | 0.694 | 0.411-0.965 | .046 |
Maximum tumor sizeb | 1.176 | 1.102-1.255 | .000 | 1.139 | 1.049-1.237 | .002 |
AFPc | 1.894 | 1.390-2.580 | .000 | 1.481 | 1.064-2.060 | .020 |
Tumor numberd | 0.576 | 0.416-0.796 | .001 | |||
DBIL | 1.060 | 1.010-1.112 | .038 |
Abbreviations: HR, hazard ratio; CI, confidence interval; AFP, α-fetoprotein; DBIL, direct bilirubin; TACE, transarterial chemoembolization; KA, Kang’ai injection.
Group: TACE + KA = 2, TACE = 1.
Maximum tumor size: 3.1-5.0 cm = 1, 5.1-10.0 cm = 2, ≥10.1 cm = 3.
AFP <200 ng/mL = 1, 200-1000 ng/mL = 2, >1000 ng/mL = 3.
Tumor number: 1 tumor = 1, 2-3 tumors = 2, ≥4 tumors = 3.